Specialty Pharmacy

GBR 310 is a recombinant DNA-derived monoclonal antibody for the treatment of allergic asthma and chronic idiopathic urticaria.

Findings may lead to the development of a noninvasive clinical diagnostic test.

The risk of comorbid chronic obstructive pulmonary disorder in patients infected with HIV may be underestimated.

Eric Peacock, CEO of MyHealthTeams, discusses effective treatment of patients with chronic conditions.

Specialty pharmacy is the fastest growing segment thanks to drug innovation that is driving health care costs.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses how the needs of specialty pharmacy, payers, and manufacturers can be aligned.

Patients in rural areas who have diabetes often have lower access to care and are more likely to be uninsured.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses high drug costs and the specialty pharmacy patient.

Officials with the FDA have approved the supplemental new drug application (sNDA) for BioDelivery Sciences International's buprenorphine and naloxone buccal film (Bunavail).

Cutting supply of essential nutrients restrains tumors.

Estimates of patients with HCV dropped from 130 million to 71 million.

Blood test quickly and accurately identifies genetic mutations linked to non-small cell lung cancer.

Key factor helps drive metastases in aggressive cancers.

Rinku A. Patel, PharmD, RPh, discusses how to improve communication among patients, physicians, pharmacists, and payers.

Interstitial lung disease, a common complication of rheumatoid arthritis, often leads to deteriorating health.

The Hematology Oncology Pharmacy Association (HOPA) is hosting the HOPA Policy Summit on Drug Waste in the Treatment of Cancer with health care professionals and industry members.

The FDA has approved Aurobindo Pharma’s generic version of olmesartan medoxomil and hydrochlorothiazide tablets in 20 mg/12.5 mg, 40 mg/12.5 mg, and 40 mg/25 mg doses.

The transition to value-based reimbursement is likely to shape the future of health care.

Study provides first direct evidence of HIV persistence in tissue macrophages in vivo, which could lead to a cure for HIV.

Cheryl Allen, vice president of Industry Relations at Diplomat, discusses how specialty pharmacies can best position themselves to access limited distribution drugs.

Pitavastatin lowered LDL cholesterol levels in patients with HIV and dyslipidemia.

Fingolimod (Gilenya) reduced disease progression in patients with relapsing-remitting multiple sclerosis.

Cerliponase alfa (Brineura) is the first treatment approved to treat a form of Batten disease.

Top news of the week in oncology and cancer drug development.

A patient discusses the struggle of receiving treatment for triple negative breast cancer in a rural community.

Major life events regarding close personal relationships may play a role in mortality.

Statins could be used as adjuvant therapy to prevent decompensation, study suggests.

Top five articles of the week from Specialty Pharmacy Times.